Hypothalamic CART is a new anorectic peptide regulated by leptin. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S (1998) Nature 393: 72-6 Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents. Scarlett JM, Rojas JM, Matsen ME, Kaiyala KJ, Stefanovski D, Bergman RN, Nguyen HT, Dorfman MD, Lantier L, Wasserman DH, Mirzadeh Z, Unterman TG, Morton GJ, Schwartz MW (2016) Nat Med 22: 800-6 Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. Torres TP, Catlin RL, Chan R, Fujimoto Y, Sasaki N, Printz RL, Newgard CB, Shiota M (2009) Diabetes 58: 78-86 Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats. Torres TP, Fujimoto Y, Donahue EP, Printz RL, Houseknecht KL, Treadway JL, Shiota M (2011) Diabetes 60: 2225-33 Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Fujimoto Y, Torres TP, Donahue EP, Shiota M (2006) Diabetes 55: 2479-90 PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Ellacott KL, Lawrence CB, Rothwell NJ, Luckman SM (2002) Endocrinology 143: 368-74 Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin. Liu HY, Collins QF, Moukdar F, Zhuo D, Han J, Hong T, Collins S, Cao W (2008) J Biol Chem 283: 12056-63 Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity. Ueta K, O'Brien TP, McCoy GA, Kim K, Healey EC, Farmer TD, Donahue EP, Condren AB, Printz RL, Shiota M (2014) Am J Physiol Endocrinol Metab 306: E1225-38 Defect in glucokinase translocation in Zucker diabetic fatty rats. Fujimoto Y, Donahue EP, Shiota M (2004) Am J Physiol Endocrinol Metab 287: E414-23 Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes. Jacobson PB, von Geldern TW, Ohman L, Osterland M, Wang J, Zinker B, Wilcox D, Nguyen PT, Mika A, Fung S, Fey T, Goos-Nilsson A, Grynfarb M, Barkhem T, Marsh K, Beno DW, Nga-Nguyen B, Kym PR, Link JT, Tu N, Edgerton DS, Cherrington A, Efendic S, Lane BC, Opgenorth TJ (2005) J Pharmacol Exp Ther 314: 191-200 Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Culnan DM, Albaugh V, Sun M, Lynch CJ, Lang CH, Cooney RN (2010) Am J Physiol Gastrointest Liver Physiol 299: G751-60 A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes. Shin JS, Torres TP, Catlin RL, Donahue EP, Shiota M (2007) Am J Physiol Regul Integr Comp Physiol 292: R1381-90 Uptake and utilization of metabolites in specific brain sites relative to feeding status. Kasser TR, Deutch A, Martin RJ (1986) Physiol Behav 36: 1161-5 A novel rat model for the study of deficits in bone formation in type-2 diabetes. Liu Z, Aronson J, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Cockrell GE, Skinner RA, Lumpkin CK (2007) Acta Orthop 78: 46-55 Mesencephalic dopamine modulation of pituitary and central beta-endorphin: relation to food intake regulation. Deutch AY, Martin RJ (1983) Life Sci 33: 281-7 Expression and shifting subcellular localization of the transcription factor, Foxd3, in embryonic and adult pancreas. Perera HK, Caldwell ME, Hayes-Patterson D, Teng L, Peshavaria M, Jetton TL, Labosky PA (2006) Gene Expr Patterns 6: 971-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.